These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2546490)

  • 1. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA; O'Donnell JJ; Mills J
    Antimicrob Agents Chemother; 1989 May; 33(5):736-41. PubMed ID: 2546490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    Walmsley SL; Chew E; Read SE; Vellend H; Salit I; Rachlis A; Fanning MM
    J Infect Dis; 1988 Mar; 157(3):569-72. PubMed ID: 2830347
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
    Palestine AG; Polis MA; De Smet MD; Baird BF; Falloon J; Kovacs JA; Davey RT; Zurlo JJ; Zunich KM; Davis M
    Ann Intern Med; 1991 Nov; 115(9):665-73. PubMed ID: 1656826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foscarnet for CMV retinitis.
    Wood CA
    Lancet; 1992 Feb; 339(8791):501. PubMed ID: 1346861
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    Polis MA
    Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foscarnet therapy of cytomegalovirus retinitis in AIDS.
    Fanning MM; Read SE; Benson M; Vas S; Rachlis A; Kozousek V; Mortimer C; Harvey P; Schwartz C; Chew E
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):472-9. PubMed ID: 2157835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.
    Aweeka F; Gambertoglio J; Mills J; Jacobson MA
    Antimicrob Agents Chemother; 1989 May; 33(5):742-5. PubMed ID: 2546491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG
    J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 11. Foscarnet sodium.
    Minor JR; Baltz JK
    DICP; 1991 Jan; 25(1):41-7. PubMed ID: 1848959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
    Jacobson MA
    Am J Med; 1992 Feb; 92(2A):26S-29S. PubMed ID: 1310573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet for cytomegalovirus retinitis.
    Singer DR; Fallon TJ; Schulenburg WE; Williams G; Cohen J
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):962. PubMed ID: 2998255
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

  • 15. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS.
    Farthing C; Anderson MG; Ellis ME; Gazzard BG; Chanas AC
    J Med Virol; 1987 Jun; 22(2):157-62. PubMed ID: 3039052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.
    Chrisp P; Clissold SP
    Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Katlama C; Dohin E; Caumes E; Cochereau-Massin I; Brancon C; Robinet M; Rogeaux O; Dahan R; Gentilini M
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S18-24. PubMed ID: 1318363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison.
    Moyle G; Harman C; Mitchell S; Mathalone B; Gazzard BG
    J Infect; 1992 Jul; 25(1):21-7. PubMed ID: 1326012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
    Jacobson MA; O'Donnell JJ
    J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S11-5. PubMed ID: 1848616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.